Endo USA, Inc has expanded its recall of clonazepam orally disintegrating tablets due to a packaging error that could be life-threatening. The company has identified that certain product lots contain cartons printed with incorrect strength and National Drug Code due to an error by a third-party packager. Consuming a higher dose of clonazepam could lead to adverse events like sedation and respiratory depression. The recall includes 16 lots of the drug distributed nationwide in blister strips containing six tablets each. Consumers are advised to stop using the product and contact their physician if they have taken an incorrect dose. Adverse reactions can be reported to the FDA MedWatch program.
Source link
Clonazepam Recall Grows Over Dangerous Labelling Error
